Savara
Tracked across 3 events · 18 articles · First seen Sep 18, 2025 · Last active Jun 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Savara is facing a class action lawsuit for allegedly issuing materially false and/or misleading statements regarding its drug MOLBREEVI BLA, which could lead to financial losses for the company and its shareholders.
Sep 18, 2025 · 6 articles
Regulatory
Impact: Savara is the target of a class action lawsuit due to alleged misrepresentations regarding its MOLBREEVI Biologics License Application, which led to a significant drop in its stock price.
Oct 06, 2025 · 6 articles
Business
Impact: Savara Inc. is the target of a class action securities lawsuit due to alleged false statements and concealment regarding its MOLBREEVI BLA, leading to investor losses.
Oct 06, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Savara live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard